Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia

NCT: NCT07658508 · ACTIVE_NOT_RECRUITING

NCT IDNCT07658508
StatusACTIVE_NOT_RECRUITING
Start Date2025-07-16
Completion2026-09-10
SponsorAlexandria University (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to learn if calcipotriol and photodynamic therapy are equally effective in treatment of leukoplakia or not. The main questions it aims to answer are: do lesions decrease or disappear when treated by calcipotriol or PDT? does the drug affect the salivary biomarkers Participants will: Take calcipotriol daily for 4 weeks or perform 4 PDT sessions over 4 weeks measure changes in salivary biomarkers be followed up for 3 months

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑